ProPhase Labs wants cold sufferers to put away their tissues and tonics and take Cold-EEZE lozenges instead. The firm contends that its Cold-EEZE remedy (a zinc-based nutritional formula available in lozenge, tablet, liquid, and gum forms) lessens the length and severity of the common cold. ProPhase markets its products primarily in the US market. The company's Pharmaloz Manufacturing subsidiary makes Cold-EEZE lozenges and provides contract manufacturing of lozenges for other firms. ProPhase is also conducting research and development programs into potential new OTC medicines.